In addition, our pan-cancer analysis showed that RIPK2-induced activity scores are strongly (rho = 0.88 on average) correlated with MYC activity scores across all the 32 cancer types (Supplementary Fig. 17). This evidence concerns the gene RIPK2 and cancer.